state officials urge support for landmark $26 bln opioid settlementĭistributors can't 'second-guess' opioid scripts, W. 400000/2017.įor Suffolk: Jayne Conroy of Simmons Hanly Conroyįor Nassau: Hunter Shkolnik of Napoli Shkolnikįor New York: John Oleske of the New York Attorney General's officeįor Endo: James Herschlein of Arnold & Porter Henninger Bullock of Mayer Brownįor Teva: Nancy Patterson of Morgan, Lewis & Bockiusįor Allergan: Mike Brock of Kirkland & Ellisĭrugmaker Endo settles opioid claims by Tennessee counties, cities for $35 mln Our decades of proven success come from passionate team members around the globe collaborating to bring the best treatments forward. The case is In Re Opioid Litigation, Suffolk Supreme Court, No. Compliance Vice President, Quality at Endo Verified Louis Donato is a Compliance Vice President, Quality at Endo based in Dublin, Leinster. Endo is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Prior to joining Rocket, Martin was General Counsel and Chief Corporate. The CDC earlier this month said provisional data showed 69,710 opioid overdose deaths in 2020, up more than 36% from the previous year. Martin Wilson is the General Counsel and Chief Compliance Officer for Rocket Pharma. Centers for Disease Control and Prevention. Nearly 500,000 people across the country have died from opioid overdoses from 1999 to 2019, according to the U.S.
Senior Vice President & Chief Compliance Officer at Endo. SVP Global Quality Compliance and Systems at Takeda Pharmaceuticals. Endo, along with its co-defendant drugmakers AbbVie Inc and Teva Pharmaceutical Industries Ltd, are not part of that deal. Senior Vice President, Global Supply Chain and Logistics. Johnson & Johnson and the nation's three largest distributors have offered to settle claims nationwide for $26 billion. McGuinness has responsibility for the Company’s overall global quality and compliance.
#Endo pharma vp compliance quality trial
More than 3,000 lawsuits have been filed by state and local governments accusing opioid manufacturers of falsely marketing opioid drugs as safe, and distributors and pharmacies of ignoring red flags that they were being used illegally, fueling a nationwide epidemic.Ī trial is also underway against drugmakers in California, and another concluded last week against distributors in West Virginia. Michael (Mick) McGuinness was appointed Global Head of Quality and Compliance, effective June 2022.
0 kommentar(er)
